These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
593 related articles for article (PubMed ID: 10510393)
1. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. Khan IA; Casciotti L J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393 [TBL] [Abstract][Full Text] [Related]
2. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice. Khan IA; Kasper LH J Immunol; 1996 Sep; 157(5):2103-8. PubMed ID: 8757333 [TBL] [Abstract][Full Text] [Related]
3. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963 [TBL] [Abstract][Full Text] [Related]
4. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. Gazzinelli RT; Hakim FT; Hieny S; Shearer GM; Sher A J Immunol; 1991 Jan; 146(1):286-92. PubMed ID: 1670604 [TBL] [Abstract][Full Text] [Related]
5. Augmentation of the CD8+ T cell response by IFN-gamma in IL-12-deficient mice during Toxoplasma gondii infection. Ely KH; Kasper LH; Khan IA J Immunol; 1999 May; 162(9):5449-54. PubMed ID: 10228024 [TBL] [Abstract][Full Text] [Related]
6. A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice. Khan IA; Ely KH; Kasper LH J Immunol; 1991 Nov; 147(10):3501-6. PubMed ID: 1940350 [TBL] [Abstract][Full Text] [Related]
7. IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii. Kasper LH; Matsuura T; Khan IA J Immunol; 1995 Nov; 155(10):4798-804. PubMed ID: 7594482 [TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii. Khan IA; Matsuura T; Kasper LH J Immunol; 1998 Sep; 161(6):2994-3000. PubMed ID: 9743363 [TBL] [Abstract][Full Text] [Related]
9. Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain. Scharton-Kersten T; Caspar P; Sher A; Denkers EY Exp Parasitol; 1996 Nov; 84(2):102-14. PubMed ID: 8932760 [TBL] [Abstract][Full Text] [Related]
10. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii. Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720 [TBL] [Abstract][Full Text] [Related]
11. Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells. Lütjen S; Soltek S; Virna S; Deckert M; Schlüter D Infect Immun; 2006 Oct; 74(10):5790-801. PubMed ID: 16988257 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690 [TBL] [Abstract][Full Text] [Related]
14. Protective immunity against lethal anaphylactic reaction in Toxoplasma gondii-infected mice by DNA vaccination with T. gondii-derived heat shock protein 70 gene. Kikumura A; Fang H; Mun HS; Uemura N; Makino M; Sayama Y; Norose K; Aosai F Parasitol Int; 2010 Jun; 59(2):105-11. PubMed ID: 20346412 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii. Xue M; He S; Cui Y; Yao Y; Wang H Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Qu D; Wang S; Cai W; Du A Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785 [TBL] [Abstract][Full Text] [Related]
17. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii. Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472 [TBL] [Abstract][Full Text] [Related]
18. Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA. Dimier-Poisson I; Aline F; Bout D; Mévélec MN Vaccine; 2006 Mar; 24(10):1705-9. PubMed ID: 16256251 [TBL] [Abstract][Full Text] [Related]
19. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979 [TBL] [Abstract][Full Text] [Related]
20. [Construction of multi-epitope DNA vaccine for Toxoplasma gondii and the study on protective immunity response in mice]. Shi L; Liu S; Cheng YB; Fan GX; Yuan YK; Ai L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):689-91. PubMed ID: 18616913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]